Ads
related to: Renal Cell Carcinoma- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Patient Resources
Find Patient Resources
On The Official Site.
- FAQs
Search results
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 6 days agoParticipants in the trial include individuals with unresectable and metastatic non-small cell lung...
Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $23.00 at JMP Securities
ETF DAILY NEWS· 11 hours agoIovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price lowered by research analysts at JMP Securities from $25.00 to $23.00 in a note issued to investors on Thursday, Benzinga ...
First patients enrolled on Veris’ CCP pilot programme
Medical Device Network via Yahoo Finance· 6 days agoIn March 2024, Elekta and Merck & Co (MSD) teamed up to enhance care for individuals with advanced ...
Updates from the 2022 WHO classification of kidney epithelial tumors
Medical Xpress· 2 days agoThe World Health Organization (WHO) and the International Society of Urologic Pathology (ISUP) have...
Three Japanese Exchange Growth Companies With High Insider Ownership And 15% Earnings Growth
Simply Wall St. via Yahoo Finance· 3 days agoAmidst a backdrop of mixed performance in global markets, Japan's stock markets have shown...
Radiopharma biotech Telix drops $200M Nasdaq IPO plans at last minute
FierceBiotech· 6 days agoInvestors celebrating the summer resurgence of biotech IPOs might want to put the champagne back on...
BeiGene, Ltd. (NASDAQ:BGNE) Short Interest Update
ETF DAILY NEWS· 4 days agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,560,000 shares, a drop of 6.6% ...
Sivia Capital Partners LLC Invests $226,000 in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 3 days agoSivia Capital Partners LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 9,436 shares of the biotechnology ...
Chicago Partners Investment Group LLC Grows Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 2 days agoChicago Partners Investment Group LLC raised its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 15.0% during the 4th quarter, HoldingsChannel.com reports. The fund ...
HUTCHMED (NASDAQ:HCM) Sees Large Volume Increase
ETF DAILY NEWS· 6 days agoHUTCHMED (China) Limited (NASDAQ:HCM – Get Free Report) saw strong trading volume on Wednesday . 314,021 shares were traded during trading, an increase of 153% from the previous session’s volume ...
Ads
related to: Renal Cell Carcinoma
